Medlabs Genetics – Trademark Portfolio

Entity Type: 03

Medlabs Genetics holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include AMPLISURE and AMPLISWAB. The owner is based in Cedar Knolls, NJ.

Dept of IT

85 Horsehill Road

Cedar Knolls, NJ 07927

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Medlabs Genetics's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Medlabs Genetics have?

Medlabs Genetics has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 1 cancelled.

What trademark classes does Medlabs Genetics file in?

Medlabs Genetics files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Medlabs Genetics's most well-known trademarks?

Medlabs Genetics's registered trademark portfolio includes well-known marks such as AMPLISURE and AMPLISWAB. These are among 2 currently registered trademarks in the portfolio.

What is Medlabs Genetics's trademark registration success rate?

Medlabs Genetics has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.